Today: 21 May 2026
BREAKING: Exxon Sues California, Citing ‘Free Speech’ in Climate Lawsuitreuters.comtimesunion.com
31 October 2025
4 mins read

ExxonMobil (XOM) Stock Dips on Mixed Earnings – What Investors Need to Know

  • Price & Performance: XOM closed around $114.6 on Oct. 30, 2025 (in a $97.8–$123.2 52-week range). It has trended modestly higher (+1–2%) over 6–12 months. In premarket trading Oct. 31 it was near ~$112.7 (–1.6%). The stock trades with a dividend yield ~3.5% on its $4.12 annual payout.
  • Recent News: In the past week Exxon reported Q3 2025 results, beat profit forecasts, but slightly missed revenue targetsng.investing.com. It announced a 4% increase in the quarterly dividend (to $1.03) and $9.4B of shareholder returnscorporate.exxonmobil.com. Other headlines: it named veteran oil executive Gregory Garland to its boardkfgo.com, and filed suit against California over new climate-disclosure rulesreuters.com. CEO Darren Woods has also publicly criticized EU climate policies as “bone-crushing”worldoil.com.
  • Analyst Views: Wall-Street consensus is cautiously positive. XOM has a Moderate Buy consensus rating, with average 12‑month price targets around $127 (about 10–11% above current). Analysts expected Q3 EPS roughly $1.79–$1.83; the company delivered ~$1.76 GAAP (about $1.88 excluding items). For full-year 2025, analysts project EPS near ~$6.8 (down ~13% YoY). Charts show strong technical momentum – XOM is up ~3.1% in 1 month and ~8.0% in 6 months, trading above its main moving averages, with support around ~$108–115 and key resistance near ~$119.
  • Fundamentals & Outlook: Exxon’s Q3 net income was $7.548B ($1.76/share GAAP), up 7% from Q2. Free cash flow was robust ($6.3B in Q3, $20.6B YTD). YTD 2025 earnings are $22.3B vs $26.1B last year (impacted by weaker oil/chemical margins). The company returned $9.4B in Q3 to shareholders and will pay a $1.03 Q4 dividend. It boasts very strong balance-sheet metrics: debt-to-capital just 13.5% (net-debt 9.5%), well below peers. Notably, Exxon set production records in core areas – Guyana output topped 700,000 barrels/day and Permian output ~1.7 million boe/day – which helped offset lower oil prices. The company is also cutting costs: it plans up to $600M of restructuring (including ~2,000 job cuts) to streamline operations.
  • Short- & Long-Term Forecasts: Analysts’ average 1‑year price targets (~$125–130) imply modest upside. Many see XOM as a value/dividend stock: for example, Zacks gives it a neutral/hold rating ahead of earnings. Chart analysts point out that XOM has been consolidating near the top of its recent trading range, so a breakout above ~$119 could spark further gains. Longer-term, forecasts vary widely; some models (coincodex, Stockscan) project mid-$130s–$150s by 2026–27, but these should be viewed cautiously. The consensus view is that Exxon’s profits will grow more slowly than before due to energy-market headwinds, even as it benefits from new projects.
  • Market & Macro Trends: The oil market backdrop is mixed. Brent crude is trading in the mid-$60s (around $64–65) and WTI near $60ng.investing.com, weighed down by rising OPEC+ output. A Reuters poll notes Brent is forecast to average ~$68 in 2025reuters.com, with analysts warning that “rising output from OPEC+” has kept the market well-supplied even as demand growth “is slowing, particularly in OECD economies”reuters.com. OPEC+ has been increasing quotas (adding ~2.7M bpd since April) and is reportedly planning more in Decemberreuters.com. DBS analyst Suvro Sarkar observes the group’s policy seems “driven by a desire to gain market share rather than support oil prices”reuters.com. In this environment, some forecasters fear a global oil surplus in 2026. On the demand side, the IEA reports oil demand growth has decelerated (about +0.8% in 2024) as efficiency and EVs curb use in developed marketsiea.org. All told, energy analysts say Exxon’s earnings outlook will hinge on oil prices, refining margins and its high-return projects (like Guyana), and on maintaining capital discipline.
  • Competitor Snapshot: Exxon’s performance can be contrasted with Chevron (CVX) and Shell (SHEL). Chevron’s Q3 EPS ($1.85 adj.) beat estimates thanks to its Hess acquisition – Reuters notes Chevron hit a record 4.1M boe/day of production and CFO Eimear Bonner said free cash flow will keep growingreuters.comreuters.com. RBC’s Biraj Borkhataria commented Chevron’s results were “strong, with every business and region beating market expectations,” reflecting “continued momentum” and new production from the Hess dealreuters.com. Shell also beat Q3 profit forecasts ($5.4B vs $5.09B expectedreuters.com) on strong LNG and refining margins, though its earnings fell year-over-year. Shell CEO Wael Sawan warned that global oil markets could face oversupply in 2026, calling that a “credible scenario”reuters.com. Over the past year, XOM has lagged some peers: for instance Zacks notes XOM is up ~2.2% YTD, versus +8.8% for Chevron and +26% for BPnasdaq.com. Investors watch Exxon partly as a proxy for integrated oils; it benefits from lower costs and dividends but currently trades with less upside than some smaller rivals.
  • Geopolitical/ESG Factors: Exxon must navigate regulatory and ESG headwinds. Recently it suited California to block new climate-disclosure laws (SB 253/261), arguing they violate its First Amendment rights by forcing it to “trumpet California’s preferred message”reuters.comlatimes.com. This reflects broader tensions: Exxon’s management has clashed with strict environmental rules in Europe (Woods labeled an EU corporate sustainability law “bone-crushing”worldoil.com) and even praised the pro-energy stance of some U.S. leaders. On the sustainability front, Exxon touts its cash returns to investors (dividends, buybacks) while slowly investing in lower-carbon energy (carbon capture, hydrogen, etc.), but critics point out it still spends most capital on oil & gas. Geopolitically, Exxon’s oil projects in places like Guyana, Iraq (new Majnoon field deal) and Nigeria give it exposure to global supply risks. For example, recent U.S. sanctions on Russian oil and the Middle East conflicts (Gaza ceasefire, Yemen unrest) can tighten markets. Reuters notes that while the Gaza ceasefire has “eased regional risk premiums,” new sanctions on Russia have “introduced fresh supply concerns”reuters.com. All these factors – climate policy, geopolitics and oil-market dynamics – add uncertainty to Exxon’s long-term outlook.

Sources: Company reports and news (Exxon Q3 results; Investing.com), Reuters, IEA and industry analysis, plus analyst forecasts and technical commentary, as cited above.

Stock Market Today

  • SpaceX Set to Go Public: Key Details and Market Impact
    May 20, 2026, 8:02 PM EDT. SpaceX, founded by Elon Musk, is poised to go public, joining hundreds of companies that raised $70 billion in U.S. equity markets last year. Going public means the company will offer shares for sale on stock exchanges, allowing investors to buy ownership stakes. This move could unlock significant capital for SpaceX's ambitious space ventures, while providing early investors a chance to realize gains. The offering is closely watched amid a strong appetite for tech and aerospace stocks, reflecting broader market interest in innovation-driven firms.

Latest articles

SPAC ETF Up as SpaceX Heads for SPCX Ticker

SPAC ETF Up as SpaceX Heads for SPCX Ticker

21 May 2026
The SPAC and New Issue ETF, now trading as SPCK, closed up 0.64% at $22.09 on Wednesday after SpaceX filed for a $75 billion IPO under the fund’s old ticker. The fund reported $7.14 million in net assets and 41 holdings as of May 19. New listings included a $75 million IPO from Research Alliance III and filings from FutureCorp Space Acquisition 1 and JAB Acquisition I. The SEC proposed easing share issuance rules for public companies.
EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

EnerSys Stock Flips After Earnings as Guidance Tops Trader Hopes

21 May 2026
EnerSys shares rose in after-hours trading after the company posted fourth-quarter adjusted earnings of $3.19 per share on $988 million in revenue, both above analyst estimates. The stock closed regular hours down 1.3% at $214.56, then quoted up 5.8% to $227. First-quarter profit guidance also topped forecasts. Management cited strong data center and defense demand, but noted continued weakness in motive-power and transportation.
Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

Silexion Soars After Cancer Study, Liquidity and Nasdaq Issues Linger for SLXN

21 May 2026
Silexion Therapeutics shares surged 97% to $0.5298 on Wednesday with over 325 million shares traded, then fell 9.5% after hours. The move followed news that Israel approved a Phase 2/3 trial of its lead pancreatic cancer drug, SIL204. Silexion reported a Q1 net loss of $2.7 million and $2.4 million in cash. The company plans a 1-for-10 reverse share split by early June.
Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally
Previous Story

Pfizer Stock Soars: Trump’s Drug-Price Deal and $7B Weight-Loss Bet Spark Rally

Amazon’s Stock Skyrockets: Q3 Beat, Cloud and AI Boom Fuel Rally
Next Story

Amazon Stock Rockets 12% After AI-Driven Cloud Surge & $2.5B FTC Win! 🚀

Go toTop